ALSO NOTED: NBTY buys Solgar; Ind-Swift expanding; Shire gets new Adderall letter; and much more...

> NBTY is buying Wyeth's Solgar Vitamin and Herb for $115 million. Story

> India's Ind-Swift is expanding its manufacturing operations. Article

> The UK's Shire Pharmaceuticals has received a second letter from Teva covering an amendment to its ANDA on a generic version of Adderall XR. Story

> Toronto-based Lorus says its cancer drug Virulizin has been granted orphan drug status in the European Union. Release

> Evotec has received its first milestone from its partnership with Boehringer Ingelheim. Release

> San Diego-based TorreyPines Therapeutics has filed an IND for NGX267, the first of several compounds in the company's product pipeline that are designed to treat Alzheimer's disease. Release

And Finally... The New York Times examines the widespread incidence of shingles and breakthrough research on a vaccine that could cure it for a majority of patients. Story